United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0254_ff2cb055-20dd-4dbc-bace-8d13e9ae4da2
Product NDC
71335-0254
Form
TABLET
Composition / generic term
Gabapentin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20060401
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-0254-1) · 71335-0254-1
  • 60 TABLET in 1 BOTTLE (71335-0254-2) · 71335-0254-2
  • 90 TABLET in 1 BOTTLE (71335-0254-3) · 71335-0254-3
  • 180 TABLET in 1 BOTTLE (71335-0254-4) · 71335-0254-4
  • 120 TABLET in 1 BOTTLE (71335-0254-5) · 71335-0254-5
  • 100 TABLET in 1 BOTTLE (71335-0254-6) · 71335-0254-6
  • 84 TABLET in 1 BOTTLE (71335-0254-7) · 71335-0254-7
  • 112 TABLET in 1 BOTTLE (71335-0254-8) · 71335-0254-8
  • 135 TABLET in 1 BOTTLE (71335-0254-9) · 71335-0254-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →